SBIR/STTR Research Award
VIRAL INACTIVATION OF INTRAVENOUS IMMUNOGLOBULIN (IVIG)
Award amount
$100,000Program and phase
SBIR · Phase IAward year
1999Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- PENTOSE PHARMACEUTICALS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Not Available The long term goal of this SBIR proposal is to provide NIMA with a low cost versatile machine neuroscience based automated image analysis system based on BCR's emerging cerebral functional unit (CFU) technology. The shorter term Phase I goal is to refine the current state of this technology and provide NIMA with a proof of concept system for NIMA's evaluation and their future R&D efforts in this field. BCR proposes to accomplish this on the basis of three milestones over 6 months as outlines in the body of this document and additionally, at NIMA's option, the delivery of a proof of concept prototype system along with the training of NIMA personnel in its use.
Technology keywords
Not reported